CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.
November 6th 2019
I was never any good at math, but I can count. So I learned to live by this bit of information by counting the days that passed after my treatments for ovarian cancer.
November 1st 2019
The Food and Drug Administration’s recent approval of Zejula for certain patients with advanced ovarian, fallopian tube or primary peritoneal cancer was the first PARP inhibitor approved for the treatment, not the maintenance, of these women.
October 30th 2019
Looking back on Day One in the chemotherapy journey.
October 23rd 2019
The Food and Drug Administration has approved Zejula for patients with advanced ovarian, fallopian tube, or primary peritoneal cancer that have been treated with three or more prior chemotherapy regimens and whose cancer is associated with homologous recombination deficiency-positive status.
October 23rd 2019
Before getting genetic testing for hereditary ovarian, breast or other cancers, make sure the company providing it is both reputable and qualified.
October 22nd 2019
"They say once you hear the word cancer, you retain maybe 40 percent of the information that follows, but the words 'ovarian cancer' got through alright."
October 8th 2019
An ovarian cancer survivor shares what she wishes she had known then with those who are newly diagnosed.
October 4th 2019
Knowing your family history is the first preventative step any woman can take to avoid a diagnosis of ovarian cancer.
October 2nd 2019
"I don’t have cancer, but here I am. This is my life. This is my reality. I am BRCA positive."
October 1st 2019
CURE spoke with an expert on how patients can better advocate for themselves when it comes to genetic testing and its follow-up.
September 30th 2019
Ovarian Cancer Research Alliance (OCRA) supports women and their families going through an ovarian cancer diagnosis, while also funding the research that will one day lead to its prevention.
September 29th 2019
Frontline maintenance therapy with Zejula lengthened time without disease progression among women with newly diagnosed, advanced ovarian cancer, according to findings from the phase 3 PRIMA study.
September 28th 2019
The addition of Lynparza to maintenance therapy with Avastin improved time to disease progression in women with advanced ovarian cancer, according results of the PAOLA-1/ENGOT-ov25 trial.
September 24th 2019
CURE spoke with an expert from Mount Sinai to discuss the future of ovarian cancer treatment and his advice for women facing a new diagnosis.
September 16th 2019
“For so long ovarian cancer has been a secret part of my life. That’s over now.”